Exact Sciences Corp (EXAS) - Financial and Strategic SWOT Analysis Review

  • ID: 4225256
  • SWOT Analysis
  • 39 pages
  • GlobalData
1 of 5

FEATURED COMPANIES

  • Cambridge Epigenetix Ltd
  • CellMax, Inc.
  • EDP Biotech Corporation
  • Epigenomics AG
  • Freenome Inc
  • GeneNews Ltd
  • MORE
Exact Sciences Corp (EXAS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities - A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Exact Sciences Corp (Exact Sciences) is a molecular diagnostic company that focuses on the early detection and prevention of various types of cancers. The company’s flagship product, Cologuard test is a non-invasive stool-based deoxyribonucleic acid (DNA) screening product indicated for the early detection of colorectal cancer and pre-cancer. It utilizes a multi-target approach to detect DNA and hemoglobin biomarkers associated with colorectal cancer. The company is also working on the development of additional tests for other types of cancers and identified proprietary methylation markers for several major cancers. It operates laboratory facilities in Madison, Wisconsin to process Cologuard tests. Exact Sciences is headquartered in Madison, Wisconsin, the US.

Exact Sciences Corp Key Recent Developments

Jun 07, 2018: Exact Sciences Announces Offering of 1.0% Convertible Senior Notes Due 2025
Jun 05, 2018: Mayo Clinic researchers take a step closer to developing a DNA test for liver cancer
Jun 05, 2018: Exact Sciences, Mayo Clinic Researchers Identify Blood-Based DNA Biomarker Panel to Accurately Diagnose Hepatocellular Carcinoma
Jan 07, 2018: Exact Sciences to report $265.5-266.5 million in revenue, 168 percent growth for 2017
Jul 25, 2017: Cologuard revenue increased to $57.6 million during second quarter; Test volume grew 149 percent from second quarter of 2016 to 135,000 completed tests

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Cambridge Epigenetix Ltd
  • CellMax, Inc.
  • EDP Biotech Corporation
  • Epigenomics AG
  • Freenome Inc
  • GeneNews Ltd
  • MORE
Section 1 - About the Company
  • Exact Sciences Corp - Key Facts
  • Exact Sciences Corp - Key Employees
  • Exact Sciences Corp - Key Employee Biographies
  • Exact Sciences Corp - Major Products and Services
  • Exact Sciences Corp - History
  • Exact Sciences Corp - Company Statement
  • Exact Sciences Corp - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Company Overview
  • Exact Sciences Corp - Business Description
  • R&D Overview
  • Exact Sciences Corp - Corporate Strategy
  • Exact Sciences Corp - SWOT Analysis
  • SWOT Analysis - Overview
  • Exact Sciences Corp - Strengths
  • Exact Sciences Corp - Weaknesses
  • Exact Sciences Corp - Opportunities
  • Exact Sciences Corp - Threats
  • Exact Sciences Corp - Key Competitors
Section 3 - Company Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Company’s Lifesciences Financial Deals and Alliances
  • Exact Sciences Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018
  • Exact Sciences Corp, Medical Equipment, Deals By Type, 2012 to YTD 2018
  • Exact Sciences Corp, Recent Deals Summary
Section 5 - Company’s Recent Developments
  • Jan 07, 2018: Exact Sciences to report $265.5-266.5 million in revenue, 168 percent growth for 2017
  • Jul 25, 2017: Cologuard revenue increased to $57.6 million during second quarter; Test volume grew 149 percent from second quarter of 2016 to 135,000 completed tests
  • Feb 21, 2017: Exact Sciences reports lower Q4 net loss, provides outlook for 2017
Section 6 - Appendix
  • Methodology
  • Ratio Definitions
  • About
  • Contact
  • Disclaimer
List of Tables
  • Exact Sciences Corp, Key Facts
  • Exact Sciences Corp, Key Employees
  • Exact Sciences Corp, Key Employee Biographies
  • Exact Sciences Corp, Major Products and Services
  • Exact Sciences Corp, History
  • Exact Sciences Corp, Subsidiaries
  • Exact Sciences Corp, Key Competitors
  • Exact Sciences Corp, Ratios based on current share price
  • Exact Sciences Corp, Annual Ratios
  • Exact Sciences Corp, Annual Ratios
  • Exact Sciences Corp, Interim Ratios
  • Exact Sciences Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018
  • Exact Sciences Corp, Medical Equipment, Deals By Type, 2012 to YTD 2018
  • Exact Sciences Corp, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Exact Sciences Corp, Performance Chart (2013 - 2017)
  • Exact Sciences Corp, Ratio Charts
  • Exact Sciences Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018
  • Exact Sciences Corp, Medical Equipment, Deals by Type, 2012 to YTD 2018
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
  • VolitionRX Limited
  • Nucleix Ltd
  • Grail Inc
  • GeneNews Ltd
  • Freenome Inc
  • Epigenomics AG
  • EDP Biotech Corporation
  • CellMax, Inc.
  • Cambridge Epigenetix Ltd
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll